FDA licenses Protein Sciences' NY plant; Hawaii Biotech looking for funding toward Ebola vaccine;

> The FDA licensed Protein Sciences' Pearl River, NY, manufacturing plant for its flu vaccine, Flublok. Story

> Hawaii Biotech and the University of Hawaii are seeking funding to develop an Ebola vaccine. News

> Corium tested its needle-free transdermal technology for flu vaccines in guinea pigs. Release

> A poll conducted on behalf of GSK ($GSK) showed that 83% of parents want their teens and young adults to be vaccinated against meningococcal disease. Release

And Finally... Uber is teaming up with South African insurance company Discovery Health to deliver vaccines door to door on May 22. For 100 rand ($8.47), users can request up to 5 vaccines to be delivered, after which a Discovery Health nurse will show up to administer the vaccines. More

Suggested Articles

Already developing coronavirus treatments, Takeda struck a licensing deal to manufacture and market Novavax's vaccine candidate in Japan

On the heels of last week's deal for 120 million Pfizer-BioNTech shots, Japan has locked down 120 million more vaccines from AstraZeneca.

The pandemic price could be lowered for larger deals, CEO Stephane Bancel said. Pfizer and BioNTech priced 100M doses at $19.50 each for the U.S.